C&SR Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$82.8K
- Investors
-
2
C&SR General Information
Description
Developer of humanized animal models and preclinical R&D services intended to improve the safety and efficacy evaluation of anticancer drugs and cell therapies. The company's platform features high-percentage human immune cell engraftment and immune reconstitution protocols, enabling clients to generate reliable clinical efficacy data through personalized humanized rodent models for oncology and immunology.
Contact Information
Website
www.cnsr.co.krCorporate Office
- Room 412, Building C
- Indeokwon IT Valley, 40 Imi-ro
- Uiwang-si, Gyeonggi-do 16006
- South Korea
Corporate Office
- Room 412, Building C
- Indeokwon IT Valley, 40 Imi-ro
- Uiwang-si, Gyeonggi-do 16006
- South Korea
C&SR Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Equity Crowdfunding | 28-Apr-2025 | $82.8K | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue |
C&SR Patents
C&SR Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025263722-A1 | Personalized humanized animal model transplanted with peripheral blood mononuclear cells (pbmcs) and production method therefor | Pending | 21-Jun-2024 | ||
| WO-2025089495-A1 | Production of ultra-advanced humanized mouse model based on umbilical cord blood-derived hematopoietic stem cell transplantation and immune cell expansion technology, and method for producing same | Inactive | 26-Oct-2023 |
C&SR Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ActnerLab | Accelerator/Incubator | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator |
C&SR FAQs
-
When was C&SR founded?
C&SR was founded in 2022.
-
Where is C&SR headquartered?
C&SR is headquartered in Uiwang-si, South Korea.
-
What industry is C&SR in?
C&SR’s primary industry is Drug Discovery.
-
Is C&SR a private or public company?
C&SR is a Private company.
-
What is C&SR’s current revenue?
The current revenue for C&SR is .
-
How much funding has C&SR raised over time?
C&SR has raised $82.8K.
-
Who are C&SR’s investors?
ActnerLab and Tech Incubator Program for Startup have invested in C&SR.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process